日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/20 | 6,740 | 6,770 | 6,670 | 6,690 | -90 | -1.3% | 277,200 |
| 2023/01/19 | 6,810 | 6,900 | 6,730 | 6,780 | -70 | -1% | 218,600 |
| 2023/01/18 | 6,740 | 6,880 | 6,720 | 6,850 | +190 | +2.9% | 199,100 |
| 2023/01/17 | 6,730 | 6,740 | 6,650 | 6,660 | -90 | -1.3% | 236,000 |
| 2023/01/16 | 6,720 | 6,810 | 6,720 | 6,750 | -30 | -0.4% | 154,200 |
| 2023/01/13 | 6,860 | 6,960 | 6,750 | 6,780 | -180 | -2.6% | 320,500 |
| 2023/01/12 | 7,100 | 7,110 | 6,950 | 6,960 | -110 | -1.6% | 196,100 |
| 2023/01/11 | 6,990 | 7,100 | 6,980 | 7,070 | +40 | +0.6% | 221,700 |
| 2023/01/10 | 7,120 | 7,200 | 7,030 | 7,030 | -40 | -0.6% | 198,500 |
| 2023/01/06 | 7,140 | 7,170 | 7,060 | 7,070 | +10 | +0.1% | 213,900 |
| 2023/01/05 | 7,080 | 7,110 | 6,970 | 7,060 | -100 | -1.4% | 334,700 |
| 2023/01/04 | 7,330 | 7,330 | 7,160 | 7,160 | -320 | -4.3% | 164,300 |
| 2022/12/30 | 7,560 | 7,600 | 7,440 | 7,480 | -40 | -0.5% | 149,900 |
| 2022/12/29 | 7,410 | 7,530 | 7,370 | 7,520 | +80 | +1.1% | 99,400 |
| 2022/12/28 | 7,400 | 7,460 | 7,340 | 7,440 | -50 | -0.7% | 179,200 |
| 2022/12/27 | 7,540 | 7,570 | 7,430 | 7,490 | +20 | +0.3% | 158,400 |
| 2022/12/26 | 7,540 | 7,540 | 7,400 | 7,470 | -80 | -1.1% | 100,900 |
| 2022/12/23 | 7,480 | 7,550 | 7,450 | 7,550 | +30 | +0.4% | 98,000 |
| 2022/12/22 | 7,530 | 7,550 | 7,460 | 7,520 | +30 | +0.4% | 167,400 |
| 2022/12/21 | 7,450 | 7,600 | 7,400 | 7,490 | +20 | +0.3% | 152,600 |
| 2022/12/20 | 7,670 | 7,720 | 7,420 | 7,470 | -210 | -2.7% | 248,200 |
| 2022/12/19 | 7,790 | 7,790 | 7,650 | 7,680 | -130 | -1.7% | 135,000 |
| 2022/12/16 | 7,930 | 7,930 | 7,760 | 7,810 | -190 | -2.4% | 187,800 |
| 2022/12/15 | 8,050 | 8,050 | 7,980 | 8,000 | -20 | -0.2% | 107,000 |
| 2022/12/14 | 7,990 | 8,040 | 7,940 | 8,020 | +90 | +1.1% | 153,100 |
| 2022/12/13 | 7,900 | 7,980 | 7,870 | 7,930 | +60 | +0.8% | 155,800 |
| 2022/12/12 | 7,860 | 7,910 | 7,810 | 7,870 | -30 | -0.4% | 124,200 |
| 2022/12/09 | 7,630 | 7,900 | 7,630 | 7,900 | +190 | +2.5% | 244,300 |
| 2022/12/08 | 7,830 | 7,840 | 7,640 | 7,710 | -80 | -1% | 214,800 |
| 2022/12/07 | 7,690 | 7,830 | 7,660 | 7,790 | +40 | +0.5% | 232,800 |
| 2022/12/06 | 7,740 | 7,840 | 7,700 | 7,750 | ±0 | ±0% | 207,800 |
| 2022/12/05 | 7,770 | 7,790 | 7,670 | 7,750 | +10 | +0.1% | 241,900 |
| 2022/12/02 | 7,810 | 7,810 | 7,720 | 7,740 | -140 | -1.8% | 394,700 |
| 2022/12/01 | 8,090 | 8,090 | 7,770 | 7,880 | -210 | -2.6% | 607,900 |
| 2022/11/30 | 8,220 | 8,240 | 8,060 | 8,090 | -230 | -2.8% | 526,100 |
| 2022/11/29 | 8,520 | 8,530 | 8,280 | 8,320 | -280 | -3.3% | 258,100 |
| 2022/11/28 | 8,700 | 8,770 | 8,570 | 8,600 | -190 | -2.2% | 204,100 |
| 2022/11/25 | 8,830 | 8,850 | 8,700 | 8,790 | +30 | +0.3% | 200,100 |
| 2022/11/24 | 8,780 | 8,880 | 8,700 | 8,760 | +90 | +1% | 192,100 |
| 2022/11/22 | 8,670 | 8,760 | 8,640 | 8,670 | +150 | +1.8% | 124,200 |
| 2022/11/21 | 8,620 | 8,640 | 8,490 | 8,520 | -50 | -0.6% | 80,000 |
| 2022/11/18 | 8,470 | 8,600 | 8,460 | 8,570 | +100 | +1.2% | 161,100 |
| 2022/11/17 | 8,450 | 8,570 | 8,440 | 8,470 | +60 | +0.7% | 99,400 |
| 2022/11/16 | 8,600 | 8,600 | 8,370 | 8,410 | -200 | -2.3% | 162,200 |
| 2022/11/15 | 8,630 | 8,680 | 8,550 | 8,610 | +120 | +1.4% | 177,100 |
| 2022/11/14 | 8,330 | 8,620 | 8,300 | 8,490 | +160 | +1.9% | 291,300 |
| 2022/11/11 | 8,110 | 8,540 | 8,090 | 8,330 | +410 | +5.2% | 368,100 |
| 2022/11/10 | 7,900 | 8,010 | 7,840 | 7,920 | -20 | -0.3% | 132,600 |
| 2022/11/09 | 7,990 | 8,020 | 7,860 | 7,940 | -90 | -1.1% | 125,400 |
| 2022/11/08 | 7,950 | 8,080 | 7,930 | 8,030 | +100 | +1.3% | 88,400 |
551～
600
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 362,200円 | +7.9% | +8.9% | 3.42% | 7.75倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 70,800円 | +21.1% | - | 0.00% | 17.58倍 | 2.47倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| サワイＧＨＤ | 196,000円 | +4.0% | +25.4% | 2.70% | 8.57倍 | 1.13倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 187,000円 | +5.0% | +1.5% | 0.00% | 16.05倍 | 4.27倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 科研薬 | 409,100円 | +30.5% | +111.0% | 4.64% | 11.53倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
